Search

Your search keyword '"Cécile Tissot"' showing total 98 results

Search Constraints

Start Over You searched for: Author "Cécile Tissot" Remove constraint Author: "Cécile Tissot"
98 results on '"Cécile Tissot"'

Search Results

1. Hormone therapy is associated with lower Alzheimer’s disease tau biomarkers in post-menopausal females -evidence from two independent cohorts

2. Identification of late-stage tau accumulation using plasma phospho-tau217Research in context

3. The relation of synaptic biomarkers with Aβ, tau, glial activation, and neurodegeneration in Alzheimer’s disease

4. Personalized whole-brain neural mass models reveal combined Aβ and tau hyperexcitable influences in Alzheimer’s disease

5. In-vivo neuronal dysfunction by Aβ and tau overlaps with brain-wide inflammatory mechanisms in Alzheimer’s disease

6. Comparison of immunoassay- with mass spectrometry-derived p-tau quantification for the detection of Alzheimer’s disease pathology

7. 14-3-3 $$\upzeta /\updelta$$ ζ / δ -reported early synaptic injury in Alzheimer’s disease is independently mediated by sTREM2

8. Surgical training strategies for physicians practicing in an isolated environment: an example from Antarctica. International survey of 13 countries with active winter stations

9. Surgical epidemiology of Antarctic stations from 1904 to 2022: A scoping review

10. Bayesian workflow for the investigation of hierarchical classification models from tau-PET and structural MRI data across the Alzheimer’s disease spectrum

11. Amyloid beta plaque accumulation with longitudinal [18F]AZD4694 PET

12. Amyloid‐dependent and amyloid‐independent effects of Tau in individuals without dementia

13. Plasma pTau181 predicts cortical brain atrophy in aging and Alzheimer’s disease

14. Comparing tau status determined via plasma pTau181, pTau231 and [18F]MK6240 tau-PET

15. Association between regional tau pathology and neuropsychiatric symptoms in aging and dementia due to Alzheimer's disease

17. Echocardiographic Evaluation of Transitional Circulation for the Neonatologists

18. Echocardiographic Evaluation of Ventricular Function—For the Neonatologist and Pediatric Intensivist

19. Basics of Functional Echocardiography in Children and Neonates

21. The Association of Age-Related and Off-Target Retention with Longitudinal Quantification of [18F]MK6240 Tau PET in Target Regions

22. Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer’s disease

23. Plasma and CSF concentrations of N‐terminal tau fragments associate with in vivo neurofibrillary tangle burden

24. Equivalence of plasma p‐tau217 with cerebrospinal fluid in the diagnosis of Alzheimer's disease

25. APOE ε4 associates with microglial activation independently of Aβ plaques and tau tangles

26. Potential Utility of Plasma P-Tau and Neurofilament Light Chain as Surrogate Biomarkers for Preventive Clinical Trials

27. Biomarker modeling of Alzheimer’s disease using PET-based Braak staging

28. Cryo-EM structure of Alzheimer’s disease tau filaments with PET ligand MK-6240

29. Astrocyte reactivity influences the association of amyloid-β and tau biomarkers in preclinical Alzheimer’s disease

30. Association of Phosphorylated Tau Biomarkers with Amyloid Positron Emission Tomography vs Tau Positron Emission Tomography

31. APOEε4 potentiates Aβ effects on longitudinal tangle accumulation via tau phosphorylation

32. Verbal memory formation across PET-based Braak stages of tau accumulation in Alzheimer’s disease

33. Apolipoprotein E ε4 associates with microglial activation in early Braak regions independently of amyloid‐β and tau

34. Impact of meningeal and age‐related off‐target binding on longitudinal [ 18 F]MK6240 quantification

35. pTau heterogeneity as a measure for disease severity in incipient Alzheimer's disease

36. TRIAD multi‐dimensional biobank for biomarker discovery

37. Verbal recognition declines in later Braak Stages compared to verbal delayed recall

38. Amyloid and tau pathologies associate with distinct aspects of the inflammatory cascade

39. Association between tau uptake and verbal fluency converge in language centers

40. Longitudinal changes in plasma p‐tau181 as a surrogate variable to populational interventions

41. Neuroinflammation is associated with the rising of early Alzheimer’s disease pathology in amyloid‐negative elderly

42. Genetic risk for attention‐deficit/hyperactivity disorder is associated with amyloid‐dependent cognitive decline in older adults

43. Mild behavioral impairment symptom severity predicts tau hyperphosphorylation assessed by plasma p‐tau181 across the Alzheimer’s disease spectrum

44. Biomarker modelling of Alzheimer's disease using in vivo Braak staging

45. Brain TSPO expression is associated with plasma pTau181 & pTau231 across the AD spectrum

46. Brain morphometric and metabolic changes in Subjective Cognitive Decline individuals

47. Tau phosphorylation is more closely associated with amyloid‐β plaques than with tau neurofibrillary tangles

48. Comparison of plasma amyloid, tau, and astrocyte biomarkers to identify AD pathophysiology

49. Association between Anxiety and Disease Pathophysiology in Participants of Longitudinal Observational Studies in Aging during the COVID-19 Lockdown

50. Intrinsic connectivity of the human brain provides scaffold for tau aggregation in clinical variants of Alzheimer's disease

Catalog

Books, media, physical & digital resources